Drug treatment of the negative symptoms of schizophrenia
- 13 January 1998
- journal article
- review article
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 8 (1) , 33-42
- https://doi.org/10.1016/s0924-977x(97)00041-2
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- ICI 204,636, an Atypical AntipsychoticJournal of Clinical Psychopharmacology, 1996
- Olanzapine versus Placebo and HaloperidolNeuropsychopharmacology, 1996
- Risperidone in the treatment of negative symptoms of schizophreniaInternational Clinical Psychopharmacology, 1995
- P-4-73 A randomized double-bind trial of risperidone versus clozapine for treatment-resistant chronic schizophreniaEuropean Neuropsychopharmacology, 1995
- Treatment of Negative Symptoms in Schizophrenia with AmisulprideThe British Journal of Psychiatry, 1995
- Effects of clozapine on positive and negative symptoms in outpatients with schizophreniaAmerican Journal of Psychiatry, 1994
- Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: a multicentre double‐blind comparative studyActa Psychiatrica Scandinavica, 1992
- Zotepine in the treatment of schizophrenic patients with prevailingly negative symptoms. A double-blind trial vs. haloperidolInternational Clinical Psychopharmacology, 1992
- Deficit and nondeficit forms of schizophrenia: the conceptAmerican Journal of Psychiatry, 1988
- Zotepine, a Neuroleptic Drug with a Bipolar Therapeutic ProfilePharmacopsychiatry, 1987